Önemli: Bu içerik kişisel tıbbi değerlendirme ve muayenenin yerine geçmez. Acil durumlarda önce doktor veya acil servise başvurun — 112.
Tests & Procedures
Svt Ablation
What is SVT ablation, how is it performed, and how are success rates and risks weighed? A source-based guide.
SVT ablation is a catheter-based treatment designed to eliminate or disable the abnormal electrical pathway or focus responsible for supraventricular tachycardia. It is often considered for recurrent, bothersome, or poorly controlled episodes of rapid heartbeat and may provide long-term relief in many appropriately selected patients. [1][2][3]
When is ablation considered?
Ablation may be considered when SVT episodes recur frequently, significantly impair quality of life, cause dizziness or near-fainting, or remain difficult to control with medication. In some patients, medications work well enough; in others, side effects, ongoing symptoms, or a desire for a more durable solution make ablation more attractive. The right timing depends on the type of SVT, symptom burden, associated heart disease, and the patient’s preferences. [2][3][4]
Some SVT mechanisms, especially AVNRT and accessory-pathway-related tachycardias, are particularly well suited to catheter ablation with high success rates in experienced hands. That said, not every episode of palpitations represents SVT, and not every fast rhythm calls for ablation first. Establishing the rhythm diagnosis as clearly as possible is a key part of decision-making. [2][4][5]
How is the procedure performed?
Ablation is usually performed through blood vessels, most often from the groin. Thin catheters are advanced into the heart, electrical mapping is carried out, and energy is delivered to the target site once the responsible pathway or focus is identified. Radiofrequency ablation is common, though cryoablation may be preferred in some settings. [1][2][5][6]
Patients are often awake with local anesthesia and sedation rather than undergoing open surgery. During the electrophysiology study, the arrhythmia may be intentionally induced in a controlled manner so the team can diagnose and treat it accurately. Although this can sound alarming, it is a routine and important part of the procedure. [1][4][5]
How should success rates and risks be understood?
Success rates are high for many common SVT types, but they vary by arrhythmia mechanism, anatomy, and operator experience. It is more accurate to discuss probabilities than guarantees. Some patients may require repeat procedures, and recurrence is possible even after a technically successful ablation. [3][4][5][6]
Risks include bleeding or bruising at the access site, infection, vascular injury, unintended rhythm problems, and in rare cases damage to the normal conduction system requiring a pacemaker. Risk depends partly on where the abnormal pathway lies, which is why individualized informed consent matters. [1][4][5]
What should be watched after the procedure?
Many patients can walk within hours and go home the same day or the next day depending on the center and clinical context. Mild groin discomfort, bruising, or brief extra beats can occur. Short-lived palpitations during healing do not automatically mean the ablation failed. [1][2][5]
However, rapidly enlarging swelling at the catheter site, fainting, persistent strong palpitations, chest pain, shortness of breath, or fever deserve medical review. Recovery advice should be followed carefully, especially regarding activity restrictions and follow-up plans. [1][2][5]
Why is pre-ablation evaluation important?
Before ablation, the goal is to determine not only that a rhythm is fast, but exactly which mechanism is responsible. AVNRT, AVRT, focal atrial tachycardia, and other supraventricular rhythms differ in technique and risk profile. Prior ECG documentation, Holter monitoring, event recording, and sometimes imaging all help refine the plan. [2][3][5]
How should long-term expectations be set?
Many patients experience major reduction or resolution of episodes after ablation, but expectations should remain realistic. Follow-up matters because recurrence, new symptoms, or uncertainty about residual palpitations may still need clarification. The value of ablation is best judged not only by the procedure day but by symptom control and safety over time. [1][2][5]
Which symptoms are considered more serious?
Palpitations accompanied by fainting, chest pain, significant shortness of breath, low blood pressure symptoms, or a family history of sudden cardiac death deserve more urgent evaluation. These findings do not always mean the rhythm is dangerous, but they increase the need for careful assessment. [2][3][5]
References
- 1.Mayo Clinic — *SVT ablation* — 2024 — https://www.mayoclinic.org/tests-procedures/svt-ablation/pyc-20385010
- 2.Mayo Clinic — *Supraventricular tachycardia - Diagnosis and treatment* — 2024 — https://www.mayoclinic.org/diseases-conditions/supraventricular-tachycardia/diagnosis-treatment/drc-20355249
- 3.NHS — *Supraventricular tachycardia (SVT)* — - — https://www.nhs.uk/conditions/supraventricular-tachycardia-svt/
- 4.ESC — *Ablation of accessory pathways: indications and contraindications* — 2021 — https://www.escardio.org/communities/councils/cardiology-practice/scientific-documents-and-publications/ejournal/volume-21/ablation-of-accessory-pathways-indications-and-contraindications/
- 5.PubMed — *Catheter ablation for supraventricular tachycardias* — 2013 — https://pubmed.ncbi.nlm.nih.gov/23834697/
- 6.PubMed — *Systematic review and meta-analysis of pulsed field ablation for PSVT* — 2025 — https://pubmed.ncbi.nlm.nih.gov/41269503/
